IT Security Compliance
Natera has completed a SOC 2 Type II Attestation Examination with an Independent Certified Public Accounting Firm for the Security Principle. SOC 2 reports are intended to meet the needs of a broad range of users that need detailed information and assurance about the controls at a service organization relevant to security, availability, and processing integrity of the systems the service organization uses to process users’ data and the confidentiality and privacy of the information processed by these systems.
Natera’s SOC 2 Compliance certification
SOC 2 (System and Organization Controls) is a regularly refreshed report that focuses on non-financial reporting controls as they relate to security, availability, and confidentiality of a cloud service.
SignateraTM is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for cancer management.
NateraTM uses revolutionary technology to enhance the patient and physician’s ability to assess otherwise undetected rejection events that might lead to loss of the transplanted organ.
NateraTM offers a full menu of high-quality genetic tests to support the entire spectrum of women’s health needs —from planning a family and prenatal testing to hereditary cancer screening.